Update on First BioNTainer for African-based mRNA

MAINZ, GERMANY, December 21, 2022 — BioNTech SE (Nasdaq: BNTX, “BioNTech”) reached the next milestone in the establishment of scalable mRNA vaccine...

Related Keywords

Germany ,Rwanda ,South Africa ,Kigali ,W09 ,Sylke Maas ,Fosun Pharma ,Pfizer ,Vp Corporate Communications ,Genentech ,African Union ,Roche Group ,New Technologies ,Private Securities Litigation Reform Act ,Quarterly Report ,Nasdaq Bntx ,Biontech Se ,Ntx ,Biontainers ,Frica ,Rna Production ,Rna Vaccines ,Afrika ,Frikanische Union ,Rna Produktion ,Mrna Impfstoffe ,